These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33530546)

  • 1. Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat.
    Matsushita Y; Nakagawa H; Koike K
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.
    Zuo Q; Wu Y; Hu Y; Shao C; Liang Y; Chen L; Guo Q; Huang P; Chen Q
    Heliyon; 2024 May; 10(9):e30807. PubMed ID: 38765144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer.
    Nassar AF; Nie X; Zhang T; Yeung J; Norris P; He J; Ogura H; Babar MU; Muldoon A; Libreros S; Chen L
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
    Butler LM; Perone Y; Dehairs J; Lupien LE; de Laat V; Talebi A; Loda M; Kinlaw WB; Swinnen JV
    Adv Drug Deliv Rev; 2020; 159():245-293. PubMed ID: 32711004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Metabolism in Cancer Cells.
    Zheng M; Wang W; Liu J; Zhang X; Zhang R
    Adv Exp Med Biol; 2021; 1316():49-69. PubMed ID: 33740243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.
    Ward AV; Anderson SM; Sartorius CA
    J Mammary Gland Biol Neoplasia; 2021 Dec; 26(4):399-417. PubMed ID: 34914014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
    Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
    Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid mediator informatics-lipidomics: novel pathways in mapping resolution.
    Serhan CN; Hong S; Lu Y
    AAPS J; 2006 Apr; 8(2):E284-97. PubMed ID: 16796379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolism in cancer.
    Santos CR; Schulze A
    FEBS J; 2012 Aug; 279(15):2610-23. PubMed ID: 22621751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism in cancer progression and therapeutic strategies.
    Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
    MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Heterogeneity of Lipid Metabolism in Cancer.
    Park JK; Coffey NJ; Limoges A; Le A
    Adv Exp Med Biol; 2021; 1311():39-56. PubMed ID: 34014533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity.
    Yoon H; Shaw JL; Haigis MC; Greka A
    Mol Cell; 2021 Sep; 81(18):3708-3730. PubMed ID: 34547235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in Cancer.
    Winkelkotte AM; Al-Shami K; Chaves-Filho AB; Vogel FCE; Schulze A
    Cold Spring Harb Perspect Med; 2024 Jul; ():. PubMed ID: 38951029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
    Pellerin L; Carrié L; Dufau C; Nieto L; Ségui B; Levade T; Riond J; Andrieu-Abadie N
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 as a Regulator of Lipid Metabolism in Cancer.
    Parrales A; Iwakuma T
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediator lipidomics.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):4-14. PubMed ID: 16099386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARα at the crossroad of metabolic-immune regulation in cancer.
    Zeng W; Yin X; Jiang Y; Jin L; Liang W
    FEBS J; 2022 Dec; 289(24):7726-7739. PubMed ID: 34480827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting dysregulated lipid metabolism in the tumor microenvironment.
    Kim DH; Song NY; Yim H
    Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
    Xu Z; Yuan KF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):561-565. PubMed ID: 34323031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.